Free Republic

Edward Gillen, 59, woke up one May morning last year and noticed a speck in his eye. The Massachusetts dad of four and beloved softball coach was just about the retire. Meanwhile, his sight was getting worse by the day. He desperately tried to nail down the cause quickly, but his vision loss deteriorated even faster. “It was Memorial Day weekend, and by June 1st, I was blind,” Gillen told the The U.S. Sun. After undergoing MRIs, CT scans and an exam from a neuro-opthalmologist, he got an answer. Doctors told him his vision loss was nonarteritic anterior ischemic optic...

Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.Ozempic, Mounjaro, and other glucagon-like peptide-1 medications, otherwise known as GLP-1s, are changing how Americans shop for groceries. In early January, Food & Wine published a story about how food companies are releasing all-new products or reimagining the marketing of old ones to appeal to more GLP-1 users who may be looking for specific nutrition needs like high-protein, high-fiber foods. In that story, we mentioned one tiny but important research paper by Cornell University that showed that households with at least one GLP-1...

Treating newly diagnosed type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin. Those are the remarkable findings of a small study. "Our findings from this admittedly small study are, nevertheless, so promising for newly diagnosed type 1 diabetes patients that we are now absolutely focused on pursuing a larger study for a longer period of time," says Paresh Dandona, MD, Ph.D. A total of 10 patients were studied, all of whom had been diagnosed in the past three to six months with type 1 diabetes. The...